Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,652
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,853.70 | 60.20 | -0.76% |
CAC 40 | 7,104.80 | 21.22 | -0.30% |
DAX 40 | 20,374.10 | 188.63 | -0.92% |
Dow JONES (US) | 40,212.71 | 619.05 | 1.56% |
FTSE 100 | 7,964.18 | 50.93 | 0.64% |
HKSE | 20,914.69 | 232.91 | 1.13% |
NASDAQ | 16,724.46 | 337.14 | 2.06% |
Nikkei 225 | 33,585.58 | 1,023.42 | -2.96% |
NZX 50 Index | 12,019.13 | 182.30 | -1.49% |
S&P 500 | 5,363.36 | 95.31 | 1.81% |
S&P/ASX 200 | 7,646.50 | 63.10 | -0.82% |
SSE Composite Index | 3,238.23 | 14.59 | 0.45% |